AR034277A1 - Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion - Google Patents

Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion

Info

Publication number
AR034277A1
AR034277A1 ARP010105391A ARP010105391A AR034277A1 AR 034277 A1 AR034277 A1 AR 034277A1 AR P010105391 A ARP010105391 A AR P010105391A AR P010105391 A ARP010105391 A AR P010105391A AR 034277 A1 AR034277 A1 AR 034277A1
Authority
AR
Argentina
Prior art keywords
pantoprazol
preparation
injection
liophilized
pantoprazole
Prior art date
Application number
ARP010105391A
Other languages
English (en)
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR034277(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of AR034277A1 publication Critical patent/AR034277A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Proceso para la producción de una preparación liofilizada que comprende 5-difluorometoxi-2-[(3,4-dimetoxi-2-pirimidinil)metilsulfinil]-1-H-bencimidazol (pantoprazol), una sal del mismo, un solvato de pantoprazol o una sal del mismo, que comprende liofilizar una solución acuosa de pantroprazol, una sal del mismo, un solvato de pantoprazol o una sal del mismo, ácido etilenodiaminotetraacético y/o una sal de adecuada del mismo, e hidróxido de sodio y/o carbonato de sodio.Se describe una preparación liofilizada de pantoprazol, así como una inyección obtenible por reconstitución de la preparación liofilizada de pantoprazol en un disolvente adecuado y un kit para inyección.
ARP010105391A 2000-11-22 2001-11-19 Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion AR034277A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00125569 2000-11-22

Publications (1)

Publication Number Publication Date
AR034277A1 true AR034277A1 (es) 2004-02-18

Family

ID=8170452

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010105391A AR034277A1 (es) 2000-11-22 2001-11-19 Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion
ARP130102967A AR092374A2 (es) 2000-11-22 2013-08-21 Preparacion liofilizada de 5-difluorometoxi-2-[(3,4-dimetoxi-2-piridinil)metilsulfinil]-1h-bencimidazol (pantoprazol)

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP130102967A AR092374A2 (es) 2000-11-22 2013-08-21 Preparacion liofilizada de 5-difluorometoxi-2-[(3,4-dimetoxi-2-piridinil)metilsulfinil]-1h-bencimidazol (pantoprazol)

Country Status (40)

Country Link
US (3) US6780881B2 (es)
EP (2) EP1339430B1 (es)
JP (1) JP4886158B2 (es)
KR (2) KR100910606B1 (es)
CN (1) CN1250292C (es)
AR (2) AR034277A1 (es)
AT (1) ATE381946T1 (es)
AU (2) AU1604202A (es)
BG (1) BG66329B1 (es)
BR (1) BRPI0115483B8 (es)
CA (2) CA2541946A1 (es)
CY (1) CY1107896T1 (es)
CZ (1) CZ304348B6 (es)
DE (1) DE60132108T2 (es)
DK (1) DK1339430T3 (es)
EA (1) EA007602B1 (es)
EC (1) ECSP034613A (es)
EE (1) EE05236B1 (es)
ES (1) ES2298295T3 (es)
GE (1) GEP20053461B (es)
HK (1) HK1060848A1 (es)
HR (1) HRP20030410B1 (es)
HU (1) HUP0303278A3 (es)
IL (2) IL155601A0 (es)
IS (1) IS2971B (es)
ME (1) ME00556A (es)
MX (1) MXPA03004548A (es)
MY (1) MY137726A (es)
NO (1) NO332937B1 (es)
NZ (1) NZ525911A (es)
PE (1) PE20020582A1 (es)
PL (1) PL201188B1 (es)
PT (1) PT1339430E (es)
RS (1) RS52024B (es)
SI (1) SI1339430T1 (es)
SK (1) SK287993B6 (es)
TW (1) TWI284041B (es)
UA (1) UA80961C2 (es)
WO (1) WO2002041919A1 (es)
ZA (1) ZA200303593B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20050287231A1 (en) * 2002-06-21 2005-12-29 Nussen Kenneth H Method and apparatus for oral hygiene products with green tea extract
CA2498276A1 (en) * 2002-10-25 2004-05-06 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
AU2003241150A1 (en) * 2003-05-06 2004-11-26 Hetero Drugs Limited Novel polymorphs of pantoprazole sodium
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
US20050004172A1 (en) * 2003-05-19 2005-01-06 Pliva-Istrazivacki Institut D.O.O. Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
WO2005070426A1 (en) * 2004-01-27 2005-08-04 Altana Pharma Ag Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection
DE102004007854A1 (de) * 2004-02-17 2005-09-01 Hexal Ag Stabile, wässrige Formulierung für Benzimidazole
US20060085924A1 (en) * 2004-10-13 2006-04-27 Gaelle Brun Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer
CN1293879C (zh) * 2005-01-20 2007-01-10 杭州华东医药集团生物工程研究所有限公司 泮托拉唑钠冻干粉针剂及其制备方法
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
WO2009001163A1 (en) * 2006-06-01 2008-12-31 Combino Pharm, S.L. Lyophilized preparations of pantoprazole sodium for injection
SI2049142T2 (sl) 2006-07-26 2016-04-29 Sandoz Ag Formulacije kaspofungina
US7979200B2 (en) * 2006-11-20 2011-07-12 Lockheed Martin Corporation Managing an air-ground communications network with air traffic control information
EP2106788A1 (en) * 2008-04-04 2009-10-07 Ipsen Pharma Liquid and freeze dried formulations
CN101744777B (zh) * 2009-12-30 2012-09-26 北京四环科宝制药有限公司 奥美拉唑钠冻干粉针剂及制备方法和检测方法
CN101961309B (zh) * 2010-09-15 2012-06-27 河南辅仁怀庆堂制药有限公司 注射用泮托拉唑钠配制工艺
CN102000034B (zh) * 2010-10-13 2011-12-21 江苏奥赛康药业股份有限公司 一种供注射用的s-泮托拉唑钠组合物及其制备方法
CN102225063B (zh) * 2011-05-10 2012-10-10 江苏奥赛康药业股份有限公司 一种供注射用的泮托拉唑钠组合物
TR201108946A2 (tr) * 2011-09-12 2012-04-24 World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu.
MX2014015269A (es) * 2012-06-27 2015-02-20 Takeda Pharmaceutical Preparaciones liquidas de aminas y acidos organicos estabilizados por sales.
CN104000786A (zh) * 2013-02-25 2014-08-27 杭州赛利药物研究所有限公司 泮托拉唑钠冻干制剂及其制备方法
CN104414979A (zh) * 2013-08-21 2015-03-18 哈药集团三精制药股份有限公司 一种泮托拉唑钠冻干粉针剂及其制备方法
CN104019635B (zh) * 2014-06-19 2015-05-27 上海慈瑞医药科技有限公司 一种兰索拉唑原料药化合物及其干燥工艺
CN104055791A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗眼角结膜炎的用途
CN104055792A (zh) * 2014-07-10 2014-09-24 北京人福军威医药技术开发有限公司 西地碘治疗中耳炎的用途
BE1021311B1 (nl) * 2014-07-31 2015-10-28 Neogen N.V. Werkwijze voor het maken van een poedervormige protonpompremmer samenstelling, genoemde samenstelling en gebruik
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN111643460A (zh) * 2020-06-30 2020-09-11 武汉九州钰民医药科技有限公司 泮托拉唑钠冻干制剂及其制备方法、由其制得的注射制剂
CN112274481A (zh) * 2020-10-27 2021-01-29 海南卫康制药(潜山)有限公司 一种注射用泮托拉唑钠组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5223515A (en) 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
WO1994002141A1 (en) 1992-07-28 1994-02-03 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
WO1994024867A1 (en) 1993-04-27 1994-11-10 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
DE4324014C2 (de) 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
TW280770B (es) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
FR2740686B1 (fr) 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
HU224987B1 (en) 1995-11-03 2006-05-29 Sanofi Aventis Stable freeze-dried pharmaceutical formulation
US5980882A (en) 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
AU1361399A (en) 1997-10-14 1999-05-03 Eisai Co. Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
WO2000026185A2 (en) 1998-10-30 2000-05-11 The Curators Of The University Of Missouri Omeprazole solution and method of using same
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1235018A (zh) * 1999-04-22 1999-11-17 沈阳东宇药业有限公司 泮托拉唑钠冻干粉针剂及制备方法
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
CA2419067C (en) * 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
AR045258A1 (es) 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion

Also Published As

Publication number Publication date
ES2298295T3 (es) 2008-05-16
EP1762249A2 (en) 2007-03-14
HUP0303278A2 (hu) 2004-01-28
PT1339430E (pt) 2008-03-27
PL361118A1 (en) 2004-09-20
US20040220228A1 (en) 2004-11-04
SK6062003A3 (en) 2003-10-07
WO2002041919A1 (en) 2002-05-30
NO20032303L (no) 2003-05-21
AU1604202A (en) 2002-06-03
CA2428870C (en) 2006-05-23
UA80961C2 (en) 2007-11-26
US8754108B2 (en) 2014-06-17
HUP0303278A3 (en) 2007-08-28
US20090093522A1 (en) 2009-04-09
CA2428870A1 (en) 2002-05-30
BG66329B1 (bg) 2013-06-28
HRP20030410A2 (en) 2005-04-30
DE60132108D1 (de) 2008-02-07
ATE381946T1 (de) 2008-01-15
US20030003058A1 (en) 2003-01-02
YU37703A (sh) 2006-05-25
NZ525911A (en) 2004-11-26
CZ304348B6 (cs) 2014-03-19
DK1339430T3 (da) 2008-05-13
IS2971B (is) 2017-05-15
KR20030055308A (ko) 2003-07-02
EA007602B1 (ru) 2006-12-29
HRP20030410B1 (en) 2011-02-28
IL155601A (en) 2008-12-29
NO332937B1 (no) 2013-02-04
IL155601A0 (en) 2003-11-23
KR100910606B1 (ko) 2009-08-04
US7351723B2 (en) 2008-04-01
JP2004513970A (ja) 2004-05-13
ME00556B (me) 2011-12-20
RS52024B (sr) 2012-04-30
MXPA03004548A (es) 2003-09-10
NO20032303D0 (no) 2003-05-21
CZ20031416A3 (cs) 2003-09-17
GEP20053461B (en) 2005-02-25
EA200300501A1 (ru) 2003-12-25
BR0115483A (pt) 2003-10-21
IS6820A (is) 2003-05-19
CY1107896T1 (el) 2013-09-04
CN1250292C (zh) 2006-04-12
CN1476335A (zh) 2004-02-18
ECSP034613A (es) 2003-08-29
EP1339430B1 (en) 2007-12-26
AR092374A2 (es) 2015-04-15
ZA200303593B (en) 2004-04-23
BG107828A (bg) 2004-07-30
JP4886158B2 (ja) 2012-02-29
EP1339430A1 (en) 2003-09-03
SK287993B6 (sk) 2012-09-03
TWI284041B (en) 2007-07-21
AU2002216042B2 (en) 2006-08-03
BRPI0115483B8 (pt) 2021-05-25
ME00556A (en) 2011-12-20
EE05236B1 (et) 2009-12-15
DE60132108T2 (de) 2008-12-11
MY137726A (en) 2009-03-31
HK1060848A1 (en) 2004-08-27
BRPI0115483B1 (pt) 2017-05-09
EP1762249A3 (en) 2014-05-14
PL201188B1 (pl) 2009-03-31
KR20080003010A (ko) 2008-01-04
PE20020582A1 (es) 2002-07-06
KR100910607B1 (ko) 2009-08-04
EE200300182A (et) 2003-06-16
SI1339430T1 (sl) 2008-06-30
CA2541946A1 (en) 2002-05-30
US6780881B2 (en) 2004-08-24

Similar Documents

Publication Publication Date Title
AR034277A1 (es) Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion
ES2026182T3 (es) Un proceso para la produccion de un solido granular adecuado para su utilizacion como polvo detergente o un compuesto del mismo.
FR2368270A1 (fr) Comprime destine au nettoyage des protheses dentaires ou d'autres appareils semblables, et procede de preparation de ce comprime
AU6266101A (en) A cleansing device for wc pans
BR0110136B1 (pt) processo de fabricaÇço de uma membrana bipolar e utilizaÇço da membrana bipolar obtida.
ATE400603T1 (de) Polybiphenylenethersulfone mit reduzierter verfärbung und verfaheren zu ihrer herstellung
TW354388B (en) Novel sulfonium salt and chemically amplified positive resist composition
AR009604A1 (es) Procedimiento para la separacion de clna de una solucion de cili
ATE68185T1 (de) Verfahren zur herstellung von 2,5-dimethylbzw. 2,5-diethyl-1,4;3,6-dianhydrosorbitol.
PE20030389A1 (es) PROCEDIMIENTO DE PREPARACION DE DERIVADOS 4,4'-DICETO-ß-CAROTENO
WO2003101452A8 (en) Process for the preparation of highly pure rabeprazole sodium salt
AR032535A1 (es) Metodo de fabricar bolsas que tienen tiras de cierre complementarias, una maquina de fabricacion, y bolsas obtenidas mediante ellos
DE50205794D1 (de) Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
CO5640096A2 (es) Formulaciones inodoras para tratar las discontinuidades mucosales
ATE104149T1 (de) Dialysier- und spuelloesung zur intraperitonealen verarbreichung.
BR112022007397A2 (pt) Composição excipiente coprocessada efervescente estável e processo para sua preparação
ATE345369T1 (de) Verfahren zur herstellung einer flüssigformulierung von salzen sulfonsaurer azofarbstoffe
PT1272495E (pt) Processo para a preparacao de cefoperazona de sodio altamente cristalina
EP1356825A4 (en) PROCESS FOR PRODUCING AN AQUEOUS DISPERSION OF CELLULOSIC DERIVATIVES
FR2816954B1 (fr) Solution aqueuse boree, realiser a partir d'un compose d'acide borique et de carbonate de sodium
CO5160306A1 (es) N-metil-o-fenilenodiamina y su proceso de obtencion
BRPI0012150B8 (pt) processo para estabilizar proteínas em misturas complexas na armazenagem em solventes aquosos, bem como de preparação de uma proteína heteróloga
DK0481253T3 (da) Nye p-oxybenzoesyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
AR026731A1 (es) Procedimiento para fabricar tienopirimidinas
BRPI0500563A (pt) processo para fabricação de embalagens em papel por meio de solução aquosa

Legal Events

Date Code Title Description
FC Refusal